These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9551668)

  • 1. Possible involvement of placental proteases in bradykinin (BK) degradation.
    Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
    Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo.
    Ichinose M; Barnes PJ
    Br J Pharmacol; 1990 Sep; 101(1):77-80. PubMed ID: 2282470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y; Maeda H; Kato H
    Agents Actions; 1990 Mar; 29(3-4):172-80. PubMed ID: 2160186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of bradykinin by angiotensin-converting enzyme and by carboxypeptidase N in human plasma.
    Kuoppala A; Lindstedt KA; Saarinen J; Kovanen PT; Kokkonen JO
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1069-74. PubMed ID: 10749699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates.
    Oliveira EB; Souza LL; Sivieri DO; Bispo-da-Silva LB; Pereira HJ; Costa-Neto CM; Sousa MV; Salgado MC
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3550-7. PubMed ID: 17906107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregate anaphylaxis and carboxypeptidase N.
    Ryan JW; Berryer P; Hart MA; Ryan US
    Adv Exp Med Biol; 1986; 198 Pt A():435-43. PubMed ID: 3028062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some characteristics of a peptidyl dipeptidase (kininase II) from rat CSF: differential effects of NaCl on the sequential degradation steps of bradykinin.
    Yoshida T; Nosaka S
    J Neurochem; 1990 Dec; 55(6):1861-9. PubMed ID: 2172462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A; Murata S; Nishio A
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):365-70. PubMed ID: 12012022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release of kininase from rat isolated hearts during myocardial ischaemia.
    Ahmad M; Zeitlin IJ; Parratt JR
    Immunopharmacology; 1996 Jun; 33(1-3):299-300. PubMed ID: 8856168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat.
    Décarie A; Raymond P; Gervais N; Couture R; Adam A
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1340-7. PubMed ID: 8897926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
    Gao XP; Suzuki H; Olopade CO; Pakhlevaniants S; Rubinstein I
    J Lab Clin Med; 1997 Oct; 130(4):395-400. PubMed ID: 9358078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.